Vitamin Deficiencies Associated with Graves' Disease
Graves' disease is primarily associated with vitamin D deficiency, and less commonly with vitamin B12 deficiency due to concurrent pernicious anemia.
Vitamin D Deficiency
Vitamin D deficiency is the most well-documented vitamin deficiency in Graves' disease patients. Multiple studies demonstrate significantly lower 25-hydroxyvitamin D levels in patients with Graves' disease compared to healthy controls 1, 2, 3.
Key Evidence:
- Vitamin D levels are inversely correlated with disease severity: Lower vitamin D status is specifically associated with increased thyrotropin-receptor antibody (TRAb) titers 2, suggesting a direct relationship between vitamin D deficiency and thyroid autoimmunity intensity
- Prevalence: The rate of vitamin D deficiency (defined as serum 25[OH]D <50 nmol/L) is significantly higher in TRAb-positive Graves' disease patients compared to healthy controls 2
- Clinical impact: Lower serum vitamin D levels (≤14.23 ng/mL) are associated with a 3-fold higher risk of Graves' disease recurrence after antithyroid drug discontinuation 4
Mechanism:
Vitamin D deficiency is recognized as an environmental risk factor for Graves' disease development 1. The association appears related to vitamin D's role in immune regulation, particularly T-cell function, which accounts for approximately 70% of genes associated with autoimmune thyroid disorders 1.
Clinical Recommendation:
Monitor 25(OH)D levels in Graves' disease patients, targeting levels above 30 ng/mL 5. For patients with autoimmune disease, including Graves' disease, supplementation should aim for 25(OH)D levels of at least 30-40 ng/mL 5. Consider empiric supplementation with 800 IU/day, with higher correcting doses if deficiency is documented 5.
Vitamin B12 Deficiency
Vitamin B12 deficiency can occur in Graves' disease patients through concurrent pernicious anemia, though this is a rare association 6.
Important Caveat:
This association is easily missed and can lead to serious complications. Pancytopenia in a Graves' disease patient may be incorrectly attributed to antithyroid drug toxicity when it is actually due to undiagnosed pernicious anemia and vitamin B12 deficiency 6. Failure to recognize this can result in delayed treatment and neurological complications 6.
Clinical Recommendation:
In Graves' disease patients presenting with pancytopenia, always check vitamin B12 levels and consider pernicious anemia before attributing hematologic abnormalities solely to antithyroid medications 6.
Other Considerations
Selenium deficiency is also mentioned as an environmental risk factor for Graves' disease 1, though the evidence provided focuses primarily on its role in disease development rather than as a consequence of the disease itself.